New TB test to speed up diagnosis
14 March 2007
The microscope sputum test is most commonly used in developing countries, where there is a disproportionately high incidence of TB. As well as being unreliable, this test must often be repeated on three occasions to yield reliable results.
Currently, the new blood test uses an expensive tool known as ELISA to detect levels of biomarkers. Scientists aim to develop the method into a simple ‘dipstick’ test that will be cheap, accurate and produce quick results.
Professor Sanjeev Krishna, Professor of Molecular Parasitology and Medicine at
About one-third of the world’s population carries the TB bacterium, Mycobacterium tuberculosis. A tenth of these will later develop the debilitating lung illness, often because their immune system is compromised by HIV infection or cancer.
"Improving diagnostic accuracy will have a massive impact on managing TB," says Professor Krishna. Treatment is a lengthy, costly process: patients must take four different antibiotics for two months, followed by two antibiotic drugs for a further four months.
"If a clinic could rule out TB infection reliably using these types of tests, this would enable valuable resources to be targeted at the patients who need treatment," Professor Krishna explains.
The initial results of the test were published in The Lancet last September.
For more information, contact media@sgul.ac.uk or to receive an alert every time we upload a news story, subscribe to the RSS feed here.

